Abstract:Neurorehabilitation and Neural Repair, Ahead of Print. ObjectiveThe aim of the paper was to investigate the composition and structure of intestinal flora in patients with cerebral ischemic stroke (CIS), and to investigate the relationship between gut microbiota (GM) and different levels of stroke severity.MethodsIn this study, 47 CIS patients (16 mild, 21 moderate, and 10 severe) and 15 healthy controls were included. General information, clinical data, and behavioral scores of the enrolled subjects were collected. Deoxyribonucleic acid in fecal intestinal flora was extracted and detected using high-throughput Illumina 16S ribosomal ribonucleic acid sequencing technology. Finally, the correlation between the community composition of intestinal microbiota and National Institutes of Health Stroke Scale (NIHSS) score in CIS patients was analyzed.ResultsCompared with healthy controls, there was no statistically significant difference in Alpha diversity among CIS patients, but the principal coordinate analysis showed significant differences in the composition of the GM among stroke patients with different degrees of severity and controls. In CIS patients, Streptococcus was significantly enriched, and Eshibacter—Shigella, Bacteroides, and Agathobacter were significantly down-regulated (P < .05). In addition, the relative abundance of Blautia was negatively correlated with the NIHSS score.ConclusionsOur results show that different degrees of CIS severity exert distinct effects on the intestinal microbiome. This study reveals the intestinal microecological changes after brain injury from the perspective of brain–gut axis. Intestinal microorganisms not only reveal the possible pathological process and indicate the severity of neurologic impairment, but also make targeted therapy possible for CIS patients.

The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke

Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.

Gut Microbiota-Mediated Ursodeoxycholic Acids Regulate the Inflammation of Microglia Through TGR5 Signaling after MCAO.

Role of the gut microbiota in complications after ischemic stroke

Gut Microbiota in Ischemic Stroke: Role of Gut Bacteria-Derived Metabolites

A potential role of gut microbiota in stroke: mechanisms, therapeutic strategies and future prospective

From Gut to Brain: Unraveling the Intricate Link Between Microbiome and Stroke

Microbiota Metabolites and Immune Regulation Affect Ischemic Stroke Occurrence, Development, and Prognosis

Crosstalk between the Gut and Brain in Ischemic Stroke: Mechanistic Insights and Therapeutic Options

Therapeutic approaches targeting the gut microbiota in ischemic stroke: current advances and future directions

Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword

The gastrointestinal-brain-microbiota axis: a promising therapeutic target for ischemic stroke

Gut Microbiota in Acute Ischemic Stroke: From Pathophysiology to Therapeutic Implications

Microbiota-gut-brain axis impairment in the pathogenesis of stroke: implication as a potent therapeutic target

The Role of the Gut Microbiota in the Development of Ischemic Stroke

Ischemic stroke and intestinal flora: an insight into brain–gut axis

Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?

Novel Mechanisms and Therapeutic Targets for Ischemic Stroke: A Focus on Gut Microbiota

The role of gut microorganisms and metabolites in intracerebral hemorrhagic stroke: a comprehensive review

Relationship Between the Gut Microbiota and Neurological Deficits in Patients With Cerebral Ischemic Stroke